Interpace Biosciences Inc. (IDXG)
Market Closed
16 Oct, 08:00 PM
OTC PINK OTC PINK Primary 
XMUN $
5. 15
-0.12
-2.277%
$
33.96M Market Cap
5.88 P/E Ratio
- Div Yield
1,800 Volume
0 Eps
$ 5.27
Previous Close Want to track IDXG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Interpace Biosciences Inc. (IDXG) Statistics
Valuation metrics
Market Cap 33.96M
Enterprise value 28.68M
Trailing P/E (ttm) 0.19
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0.84
Price/Book (mrq) 1.23
Enterprise Value/Revenue 0.79
Enterprise Value/EBITDA 5.94
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.67K
Average volume (90 days) 4.01K
Price summary
52-Week low 0.81
52-Week high 7.8
Beta -
50-Day moving average 6.35
200-Day moving average 2.83
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 27 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.68%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.71%
Return on equity 1.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.52
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.49
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 2.22%
Book value per share (mrq) 4.2
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
